Citadel Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3M | Buy |
|
|||||
|
2025
Q2 | $1.8M | Sell |
|
|||||
|
2025
Q1 | $1.43M | Buy |
|
|||||
|
2024
Q4 | $1.44M | Buy |
|
|||||
|
2024
Q3 | $171K | Sell |
|
|||||
|
2024
Q2 | $2.36M | Buy |
|
|||||
|
2024
Q1 | $210K | Buy |
|
|||||
|
2023
Q4 | $180K | Sell |
|
|||||
|
2023
Q3 | $4.08M | Buy |
|
|||||
|
2023
Q2 | $4.57M | Buy |
|
|||||
|
2023
Q1 | $4.53M | Buy |
|
|||||
|
2022
Q4 | $2.28M | Sell |
|
|||||
|
2022
Q3 | $12.1M | Buy |
|
|||||
|
2022
Q2 | $4.93M | Buy |
|
|||||
|
2022
Q1 | $5.66M | Buy |
|
|||||
|
2021
Q4 | $2.37M | Sell |
|
|||||
|
2021
Q3 | $11.6M | Buy |
|
|||||
|
2021
Q2 | $8.93M | Buy |
|
|||||
|
2021
Q1 | $9.39M | Buy |
|
|||||
|
2020
Q4 | $8.06M | Buy |
|
|||||
|
2020
Q3 | $4.57M | Buy |
|
|||||
|
2020
Q2 | $225K | Sell |
|
|||||
|
2020
Q1 | $7.81M | Sell |
|
|||||
|
2019
Q4 | $7.98M | Buy |
|
|||||
|
2019
Q3 | $2.58M | Sell |
|
|||||
|
2019
Q2 | $4.39M | Sell |
|
|||||
|
2019
Q1 | $5.25M | Buy |
|
|||||
|
2018
Q4 | $2.58M | Sell |
|
|||||
|
2018
Q3 | $5.85M | Buy |
|
|||||
|
2018
Q2 | $1.77M | Buy |
|
|||||
|
2018
Q1 | $846K | Buy |
|
|||||
|
2017
Q4 | $498K | Sell |
|
|||||
|
2017
Q3 | $687K | Sell |
|
|||||
|
2017
Q2 | $4.67M | Buy |
|
|||||
|
2017
Q1 | $3.16M | Buy |
|
|||||
|
2016
Q4 | $2.49M | Buy |
|
|||||
|
2016
Q3 | $2.03M | Buy |
|
|||||
|
2016
Q2 | $419K | Sell |
|
|||||
|
2016
Q1 | $4.94M | Buy |
|
|||||
|
2015
Q4 | $134K | Sell |
|
|||||
|
2015
Q3 | $530K | Buy |
|
|||||
|
2015
Q2 | $583K | Sell |
|
|||||
|
2015
Q1 | $3.6M | Buy |
|
|||||
|
2014
Q4 | $1.88M | Sell |
|
|||||
|
2014
Q3 | $2.67M | Buy |
|
|||||
|
2014
Q2 | $256K | Sell |
|
|||||
|
2014
Q1 | $2.42M | Buy |
|
|||||
|
2013
Q4 | $1.12M | Sell |
|
|||||
|
2013
Q3 | $1.05M | Sell |
|
|||||
|
2013
Q2 | $1.36M | Buy |
|